We administered pharmacological inhibitors of SYK and specific targeting of mice liver macrophages to investigate the role of SYK in NETosis and the mechanism of its impact on liver injury and tumor recurrence in hepatic ischemia-reperfusion injury. This evidence concerns the gene SYK and neoplasm.